Director of Outsourcing Management

The Director of Outsourcing Management (DOM) is a highly motivated, results-driven individual seeking a challenging leadership role. This position is responsible for evaluating, selecting, and collaborating with the team to effectively oversee vendors that provide critical services to Lexeo’s development team. The ideal candidate is a strategic thinker with excellent communication and organizational skills, along with a strong understanding of outsourcing processes and regulations.

This role is open to remote candidates within the United States. Some travel is required.

• Oversee and manage all complex outsourced activities for Lexeo’s Clinical Development Organization. 
• Develop and implement strategies and processes that optimize the efficiency and effectiveness of Lexeo’s outsourcing needs. 
• Ensure compliance with all relevant regulations and guidelines related to outsourcing. 
• Communicate effectively with internal stakeholders and external vendors to ensure smooth and successful outsourcing operations. 
• Monitor and evaluate vendor performance to ensure quality and timely delivery of services. 
• Develop, analyze, and report on key performance indicators to senior management. 
• Work closely with cross-functional teams to identify areas for improvement and implement solutions. 
• Develop and maintain strong relationships with vendors to foster a collaborative and productive working environment. 
• Keep up to date with industry trends and best practices in outsourcing management. 
• Develop and manage budgets for outsourcing activities. 
• Identify and mitigate potential risks associated with outsourcing activities. 
• Collaborate with legal and compliance teams to ensure all contracts and agreements with vendors are aligned with company policies and procedures. 
• Drive continuous improvement and innovation in outsourcing processes to enhance overall company performance. 
• Represent the company in vendor meetings, negotiations, and other relevant forums.

• Bachelor’s degree required; advanced degree is strongly preferred (Scientific, JD, MBA)
• 10-12 years combined experience in pharmaceutical research, legal, strategy, or financial analysis required. Pharmaceutical, licensing, CRO, or legal experience preferred. 
• Strong knowledge of drug development, project management, quality assurance, clinical and non-clinical research, legal, and regulatory functions. 
• In-depth understanding of outsourcing processes, legal, QA, and finance policies and procedures within a drug development setting.  
• Proven ability to leverage resources in a global environment without direct reporting responsibility/authority. Demonstrated leadership skills with a very broad business orientation. Responsible to teams but with no direct reporting responsibility/authority for those functional areas. 
• Proven project management skills with a track record of success in managing broad-scope projects involving cross-functional teamwork. 
• Demonstrated strategic thinking and planning skills with strong analytical capabilities to evaluate scientific and financial data, identify key issues, and establish priorities. 
• Proven negotiation skills and experience managing contracts and vendor relationships. 
• Excellent written and verbal communication skills, with experience in preparing and presenting key information to senior-level management. 
• Ability to build and sustain effective internal and external partnerships. Strong relationship management and influencing skills are required with a high degree of customer focus. 
• Problem-solving abilities at strategic and operational levels to address contract issues, supplier management and performance, cross-functional challenges, and resolution between functional areas and external suppliers.  
• Advanced analytical skills that lead to value generation, contract optimization, and risk identification. 

About Lexeo

Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease are treated. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of clinical and preclinical programs.  Lexeo successfully completed a $112M IPO in November 2023 and in early March 2024 announced a PIPE raising an additional $95M, extending the Company’s runway into 2027.

Our work culture for most roles is a hybrid model with days in the New York City office and days working from home.  We welcome applications from candidates located across the Northeast and Mid-Atlantic. Remote work can be considered for exceptional candidates.

Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.